Literature DB >> 17210154

Atherosclerosis risk factors in children of parents with the metabolic syndrome.

Gulcin Akinci1, Senol Coskun, Baris Akinci, Zeliha Hekimsoy, Petek Bayindir, Ece Onur, Bilgin Ozmen.   

Abstract

BACKGROUND: Metabolic syndrome is a constellation of disorders that produces a high risk of atherosclerosis. Endothelial dysfunction is the key event in atherosclerosis and already present even in the childhood. The aim of the present study is to investigate inflammatory and radiological signs of atherosclerosis in children who have parents with the metabolic syndrome. DESIGN AND METHODS: Fifty children of parents with the metabolic syndrome and 38 age- and sex-matched controls were studied. Anthropometric measurements, blood pressure assessment, echocardiography, flow-mediated vasodilatation (FMD) which is a non-invasive test for the evaluation of endothelial function and fasting blood measurements including blood glucose, insulin, total cholesterol, HDL cholesterol, triglyceride, hsCRP and soluble CD40 ligand were performed.
RESULTS: Serum sCD40L and hsCRP levels were significantly higher in the study group compared to the controls. FMD values did not differ between the study and control groups. Increased serum sCD40L levels were positively correlated with body mass index, waist hip ratio, LDL/HDL cholesterol ratio, and the number of metabolic syndrome components in parents, whereas showed negative correlation with the serum HDL cholesterol levels. High hsCRP levels were positively correlated with body mass index and the number of metabolic syndrome components. Multiple regression analysis demonstrated that the number of metabolic syndrome components in parents presented as being a significant predictor of the serum sCD40L and hsCRP levels of their children.
CONCLUSION: Our results suggest that children of patients with metabolic syndrome have higher values of the serum markers of inflammation, which may be associated with increased risk for development of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210154     DOI: 10.1016/j.atherosclerosis.2006.12.008

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

Review 1.  Systemic Inflammation, Oxidative Stress and Cardiovascular Health in Children and Adolescents: A Systematic Review.

Authors:  Tjaša Hertiš Petek; Tadej Petek; Mirjam Močnik; Nataša Marčun Varda
Journal:  Antioxidants (Basel)       Date:  2022-04-30

2.  Body fat distribution and its association with cardiovascular risk factors in adolescent Iranian girls.

Authors:  Naghmeh Zahra Mirhosseini; Suzana Shahar; Majid Ghayour-Mobarhan; Mohammad-Reza Parizadeh; Noor Aini Mohd Yusoff; Mohammad-Taghi Shakeri
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

3.  Elevated plasma levels of interleukin-12p40 and interleukin-16 in overweight adolescents.

Authors:  Michael Lichtenauer; Marcus Franz; Michael Fritzenwanger; Hans-Reiner Figulla; Norbert Gerdes; Christian Jung
Journal:  Biomed Res Int       Date:  2015-02-02       Impact factor: 3.411

4.  Effect of Low High-Density Lipoprotein Level on Endothelial Activation and Prothrombotic Processes in Coronary Artery Disease-A Pilot Study.

Authors:  Magdalena Lampka; Dorota Olszewska-Słonina; Iga Hołyńska-Iwan; Zofia Grąbczewska; Karolina Obońska; Anna Cwynar; Justyna Stępowska; Karolina Szewczyk-Golec
Journal:  Int J Environ Res Public Health       Date:  2022-07-15       Impact factor: 4.614

5.  The Combating Obesity in Māori and Pasifika Adolescent School-Children Study: COMPASS Methodology and Study Protocol.

Authors:  Lee Stoner; Sarah P Shultz; Danielle M Lambrick; Jeremy Krebs; Mark Weatherall; Barry R Palmer; Andrew M Lane; Geoff Kira; Trevor Witter; Michelle A Williams
Journal:  Int J Prev Med       Date:  2013-05

6.  Metabolic syndrome in different sub occupations among mine workers.

Authors:  V Dhatrak Sarang; S Nandi Subroto; L Dhumne Umesh
Journal:  Indian J Occup Environ Med       Date:  2015 May-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.